Hap Trading, LLC Astrazeneca PLC Put Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $37,947 - $49,308	700 Added 0.44%	159,300 $65,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $84,832 - $217,200	1,600 Added 1.02%	158,600 $333,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $35,556 - $42,684	-600 Reduced 0.38%	157,000 $220,000
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $2.25 Million - $2.71 Million	-40,416 Reduced 20.41%	157,600 $235,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $230,341 - $272,171	4,264 Added 2.2%	198,016 $426,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $1.42 Million - $1.55 Million	25,552 Added 15.19%	193,752 $387,000
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $6.22 Million - $7.73 Million	128,400 Added 322.61%	168,200 $314,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $75,456 - $87,104	-1,600 Reduced 3.86%	39,800 $141,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $422,124 - $504,774	8,700 Added 26.61%	41,400 $298,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $1.33 Million - $1.53 Million	-25,100 Reduced 43.43%	32,700 $180,000
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $2.49 Million - $3.2 Million	57,800 New	57,800 $97,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.